Cystatin C as an indicator of renal damage in pre-eclampsia

References

• Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet. 2005;365(9461):785–799.
   PubMed Web of Science ®Google Scholar
• Khan KS, Wojdyla D, Say L, et al. WHO analysis of causes of maternal death: a systematic review. Lancet. 2006;367(9516):1066–1074.
   PubMed Web of Science ®Google Scholar
• Laurenti R, Jorge MHPDM, Gotlieb SDL. MortalidadeMaternaNasCapitaisBrasileiras: algumasCaracterísticas E Estimativa De Um Fator De Ajuste. Revista Brasileira De Epidemiologia. 2004;7(4):449–460.
   Google Scholar
• Payne BA, Hutcheon JA, Ansermino JM, et al. A risk prediction model for the assessment and triage of women with hypertensive disorders of pregnancy in low-resourced settings: the miniPIERS (Pre-eclampsia Integrated Estimate of Risk) multi-country prospective cohort study. PloS Med. 2014;11(1):eE1001589. .
   Web of Science ®Google Scholar
• Snydal S. Major changes in diagnosis and management of preeclampsia. J Midwifery Womens Health. 2014;59(6):596–605.
   PubMed Web of Science ®Google Scholar
• American College of Obstetricians and Gynecologists. Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstet Gynecol. 2013;122(5):1122–1131. .
   PubMed Web of Science ®Google Scholar
• Garovic VD, Wagner SJ, Turner ST, et al. Urinary podocyte excretion as a marker for preeclampsia. Am J Obstet Gynecol. 2007;196(4):320.e1–7. .
   PubMed Web of Science ®Google Scholar
• White VM, Garrett AT, Craici IM, et al. Persistent urinary podocyte loss following preeclampsia may reflect subclinical renal injury. PLoS One. 2014;9(3):e92693. .
   PubMed Web of Science ®Google Scholar
• Fliser D, Ritz EJ. Serum cystatin C concentration as a marker of renal dysfunction in the elderly. Am J Kidney Dis. 2001;37(1):79–83.
   PubMed Web of Science ®Google Scholar
• Ozer BA, Dursun B, Baykal A, et al. Can cystatin C be a better marker for the early detection of renal damage in primary hypertensive patients? Ren Fail. 2005;27(3):247–253.
   PubMed Web of Science ®Google Scholar
• Hojs R, Bevc S, Ekart R, et al. Serum cystatin C as an endogenous marker of renal function in patients with mild to moderate impairment of kidney function. Nephrol Dial Transplant. 2006;21(7):1855–1862. .
   PubMed Web of Science ®Google Scholar
• Gaber LW, Spargo BH, Lindheiner MD. Renal pathology in pre-eclampsia. Baillieres Clin Obstet Gynaecol. 1994;8(2):443–468.
   PubMed Web of Science ®Google Scholar
• Willens HL, Hilbrands LB, Calseyde JF, et al. Is serum cystatin C the marker of choice to predict glomerular filtration rate in pediatric patients? Ann Clin Biochem. 2003;40:60–64.
   PubMed Web of Science ®Google Scholar
• Finney H, Newman DJ, Thakkar H, et al. Reference ranges for plasma cystatin C and creatinine measurements in premature infants, neonates and older children. Arch Dis Child. 2000;82(1):71–75.
   PubMed Web of Science ®Google Scholar
• Bökenkamp A, Domanetzki M, Zinck R, et al. Reference values for cystatin C serum concentrations in children. Pediatr Nephrol. 1998;12:125–129.
   PubMed Web of Science ®Google Scholar
• Cataldi L, Mussap M, Bertelli L, et al. Cystatin C in healthy women at term pregnancy and in their infant newborns: relationship between maternal and neonatal serum levels and reference values. Am J Perinatol. 1999;16(6):287–295.
   PubMed Web of Science ®Google Scholar
• Strevens H, Wide-Swensson D, Grubb A. Serum cystatin C is a better marker for preeclampsia than serum creatinine or serum urate. Scand J Clin Lab Invest. 2001;61(7):575–580.
   PubMed Web of Science ®Google Scholar
• Strevens H, Wide-Swensson D, Torffvit O, et al. Serum cystatin C for assessment of glomerular filtration rate in pregnant and non-pregnant women. Indications of altered filtration process in pregnancy. Scand J Clin Lab Invest. 2002;62(2):141–147.
   PubMed Web of Science ®Google Scholar
• Jacobs DS, Bernard L Jr. Laboratory Test Handbook. Hudson: Lexi-comp; 1990.
   Google Scholar
• Tietz NW. Clinical Guide to Laboratory Tests. Philadelphia: Wb Saunders Co.; 1995.
   Google Scholar
• Hoek FJ, Kemperman FA, Krediet RT. A comparison between cystatin c. Plasma creatinine and the Cockcroft and Gault formula for the estimation of glomerular filtration rate. Nephrol Dial Transplant. 2003;18(10):2024–2031.
   PubMed Web of Science ®Google Scholar
• Stevenson PH. Height-weight-surface formula for the estimation of body surface area in Chinese subjects. Chin J Physiol. 1937;12:327–334.
   Google Scholar
• Agresti A. Categorical Data Analysis. 2nd ed. New York(NY): John Wiley & Sons, Inc.; 2002. p. 320–332.
   Google Scholar
• Kristensen K, Lindström V, Schmidt C, et al. Temporal changes of the plasma levels of cystatin c, β‐trace protein, β2‐microglobulin, urate and creatinine during pregnancy indicate continuous alterations in the renal filtration process. Scand J Clin Lab Invest. 2007;67(6):612–618.
   PubMed Web of Science ®Google Scholar
• Franceschini N, Qiu C, Barrow DA, et al. Cystatin C and preeclampsia: a case control study. Ren Fail. 2008;30(1):89–95. .
   PubMed Web of Science ®Google Scholar
• Thilaganathan B, Ralph E, Papageorghiou AT, et al. Raised maternal serum cystatin c: an early pregnancy marker for preeclampsia. Reprod Sci. 2009;16(8):788–793.
   PubMed Web of Science ®Google Scholar
• Kristensen K, Larsson I, Hansson SR. Increased cystatin C expression in the pre-eclamptic placenta. Mol Hum Reprod. 2007;13(3):189–195.
   PubMed Web of Science ®Google Scholar
• Knight EL, Verhave JC, Spiegelman D, et al. Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int. 2004;65(4):1416–1421.
   PubMed Web of Science ®Google Scholar
• Ix JH, Shlipak MG, Chertow GM, et al. Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: data from the heart and soul study. Circulation. 2007;115(2):173–179.
   PubMed Web of Science ®Google Scholar
• Neri LAL, Mendes ME, David-Neto E, et al. Cystatin C measurement as renal function marker. J Bras Patol Med Lab. 2010;46:443–453.
   Google Scholar
• Sai E, Shimada K, Miyauchi K, et al. Increased cystatin C levels as a risk factor of cardiovascular events in patients with preserved estimated glomerular filtration rate after elective percutaneous coronary intervention with drug-eluting stents. Heart Vessels. 2016;31(5):694–701.
   PubMed Web of Science ®Google Scholar
• Salgado JVL. Avaliação da cistatina C comomarcador de função renal de pacientes com hipertensão arterial primária. 2010.
   Google Scholar
• Rigalleau V, Beauvieux MC, Le Moigne F, et al. Cystatin C improves the diagnosis and stratification of chronic kidney disease, and the estimation of glomerular filtration rate in diabetes. Diabetes Metab. 2008;34(5):482–489.
   PubMed Web of Science ®Google Scholar
• Yong Z, Pei X, Zhu B, et al. Predictive value of serum cystatin C for acute kidney injury in adults: a meta-analysis of prospective cohort trials. Sci Rep. 2017;7(1):41012.
   PubMed Web of Science ®Google Scholar
• De Loor J, Daminet S, Smets P, et al. Urinary biomarkers for acute kidney injury in dogs. J Vet Intern Med. 2013;27(5):998–1010.
   PubMed Web of Science ®Google Scholar
• Konvalinka A. Urine proteomics for acute kidney injury prognosis: another player and the long road ahead. Kidney Int. 2014;85(4):735–738.
   PubMed Web of Science ®Google Scholar